Q1 FY27 results: Revenue up 26%, PAT up 45% YoY; auditor changes announced

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹482.00

prior close

₹498.20

announcement price

In-mkt

timing

Nifty Microcap 250market+0.4%+2.5% vs market

Hospital peers, median of 26sector+0.1%+2.8% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 2.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.9

30m

-1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9+0.4+2.5+0.1+2.8

Next day

+7.3+1.7+5.5+0.0+7.3

+10.6+2.1+8.5+0.2+10.4

+13.6+2.1+11.5+1.2+12.3

+16.7+2.1+14.7+1.0+15.7

+12.8+1.9+10.9-0.7+13.5

+4.9+2.4+2.4-2.2+7.0

15d

+3.3+3.0+0.3-1.5+4.8

+6.7+3.7+3.0-2.9+9.6

+0.4+1.6-1.2-9.2+9.6

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY2027 consolidated (quarter ended June 30, 2026): Revenue from operations rose 26% YoY to Rs.614 crore, Total income up 23.9% to Rs.620 crore. EBITDA grew 25.2% to Rs.177 crore at 28.5% margin. PAT jumped 44.6% YoY to Rs.55 crore. Network expanded to 304 facilities with 18 new additions. Board also approved S.R. Batliboi as statutory auditors till 20th AGM (replacing Deloitte), KPMG as internal auditors, and a new wholly owned subsidiary in Nigeria.

Likely market impact

Strong quarter with double-digit revenue and PAT growth along with margin expansion signals healthy business momentum for shareholders.